Show simple item record

dc.contributor.author Buzu, Piotr
dc.date.accessioned 2021-10-06T07:56:47Z
dc.date.available 2021-10-06T07:56:47Z
dc.date.issued 2014
dc.identifier.citation BUZU, Piotr. Genetic control of hypertension. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 30. en_US
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/18090
dc.description Department of Molecular biology and Human genetics, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Republic of Moldova
dc.description.abstract Introduction: Hypertension is a multifactorial, complex and polygenic human disease that causes significant morbidity and mortality worldwide. The World Health Organization suggests that the number of people affected by hypertension will rise to 1.5 billion in 2020, or 29% of the total population by 2025. In adults there is a continuous, incremental risk of cardiovascular disease, stroke and renal disease associated with high blood pressure. Identifying risk factors for this disease is one of the main directions of research initiated by World and European scientific community. Among these, genetic factors have a decisive impact, role of genetic factors ranging from 31% to 68%.Monogenic and polygenic forms of hypertension have been described. Rare monogenic blood pressure syndromes are characterized by a major gene defect, affecting a single pathway ordinarily involving renal electrolyte balance. Thus, there is a pressing need for a greater understanding of the pathophysiological and genetic underpinnings of blood pressure regulation and dysregulation. Purpose and Objectives: characterization of the genetic factors involved in the production of high blood pressure; classification of the etiopathogenetic factors that predispose to the occurrence of hypertension; characterization of genes involved in the control of hypertension; study the distribution of the polymorphisms II, DD, ID of the ACE gene and GG, TT, GT of the NOS gene in people affected by essential hypertension and non-affected from the population of Republic of Moldova. Materials and methods: The study has included 30 persons, 15 affected by essential hypertension and 15 non-affected. Methods which have been used are DNA isolation, PCR and electrophoresis of DNA fragments. Results: The results of the analysis of the ACE genotype frequency in the study group showed an increased frequency of 55% for ID genotype in compared to 25% for II and 20% for DD genotypes. The results of the analysis of the NOS genotype frequency in the study group showed an increased frequency of 72% for GT genotype in healthy individuals, the homozygous genotypes are seen with greater frequency in affected individuals. Conclusion: There is an association between ACE and NOS gene polymorphisms with hypertension prevalence.DD genotype of ACE gene and TT genotype of NOS gene may be associated with increased risk of hypertension. en_US
dc.language.iso en en_US
dc.publisher Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association en_US
dc.relation.ispartof MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova en_US
dc.subject genetic control en_US
dc.subject hypertension en_US
dc.subject ACE en_US
dc.subject NOS en_US
dc.title Genetic control of hypertension en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2014
    The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics